Catalog #BE0503

InVivoMAb anti-human TLR4 (CD284)

Clone HTA125
Reactivities Human
Applications in vitro blocking of TLR4 signaling
ex vivo blocking of TLR4 signaling
in vitro functional assay
Flow cytometry
Immunoprecipitation
Immunohistochemistry (frozen)
Immunohistochemistry (paraffin)
Immunofluorescence
Western blot
Isotype Mouse IgG2a, κ

$178.00 - $4,651.50

$178.00 - $4.00

Choose an Option...
  • 100 mg - $4,651.50
  • 50 mg - $3,286.00
  • 25 mg - $2,183.00
  • 5 mg - $652.00
  • 1 mg - $178.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left
US Customers - Order by Noon EST on Monday to receive by November 24.

Product Description

The HTA125 monoclonal antibody reacts with human Toll-like receptor 4 (TLR4) through an epitope within the N-terminal region of its extracellular domain. TLR4 belongs to the evolutionarily conserved Toll-like receptor (TLR) family, which consists of 10 functional members in humans (TLR1-10). Human TLR4, also known as CD28, is primarily expressed in monocytes, macrophages, neutrophils, and dendritic cells (myeloid immune cells). TLR4 expression has also been reported in select non-myeloid immune cells, e.g., T cells and B cells, and nonimmune cell populations such as astrocytes, endothelial cells, epithelial cells and fibroblasts, in which its expression varies with cell differentiation and inflammatory state. Myeloid differentiation factor 2 (MD2) is essential for canonical lipopolysaccharide (LPS) recognition and TLR4 activation. Importantly, MD2 is not universally required for TLR4 cell-surface expression. Activated TLR4 recruits TIRAP and MyD88 at the plasma membrane, initiating signaling through downstream mediators, including TRAF6, to activate NF-κB and induce proinflammatory cytokines. After LPS stimulation, CD14-mediated TLR4 endocytosis promotes endosomal signaling through TRAM–TRIF/TICAM1 and the TBK1–IRF3 axis, resulting in type I interferon (IFN) production. TLR4 acts as a transmembrane pattern-recognition receptor that initiates innate immune responses, and depending upon the context, it is often studied in the pathophysiology of sepsis, endotoxic shock (from gram-negative bacterial infections), ischemia-reperfusion injury, atherosclerosis, hyperglycemia-related inflammation, osteoarthritis, cancer-associated inflammation in malignant tumors, and neuroinflammation, including processes implicated in Alzheimer’s disease. The HTA125 antibody has been reported to inhibit LPS-induced monocyte activation, highlighting its functional blocking efficacy and relevance to research on TLR4-mediated inflammatory responses.

Specifications

Isotype Mouse IgG2a, κ
Recommended Isotype Control(s) InVivoMAb mouse IgG2a isotype control, unknown specificity
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Immunogen Ba/F3 cells expressing human TLR4
Reported Applications in vitro blocking of TLR4 signaling
ex vivo blocking of TLR4 signaling
in vitro functional assay
Flow cytometry
Immunoprecipitation
Immunohistochemistry (frozen)
Immunohistochemistry (paraffin)
Immunofluorescence
Western blot
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤1EU/mg (≤0.001EU/μg)
Determined by LAL assay
Purity ≥95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from cell culture supernatant in an animal-free facility
Purification Protein G
Molecular Weight 150 kDa
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Application References

  • in vitro blocking of TLR4 signaling Flow Cytometry Immunofluorescence Immunoprecipitation
    Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M (1999). "MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4." J Exp Med 189(11):1777-82.

    Toll-like receptor 4 (TLR4) is a mammalian homologue of Drosophila Toll, a leucine-rich repeat molecule that can trigger innate responses against pathogens. The TLR4 gene has recently been shown to be mutated in C3H/HeJ and C57BL/10ScCr mice, both of which are low responders to lipopolysaccharide (LPS). TLR4 may be a long-sought receptor for LPS. However, transfection of TLR4 does not confer LPS responsiveness on a recipient cell line, suggesting a requirement for an additional molecule. Here, we report that a novel molecule, MD-2, is requisite for LPS signaling of TLR4. MD-2 is physically associated with TLR4 on the cell surface and confers responsiveness to LPS. MD-2 is thus a link between TLR4 and LPS signaling. Identification of this new receptor complex has potential implications for understanding host defense, as well as pathophysiologic, mechanisms.

  • in vitro blocking of TLR4 signaling
    Kawai K, Shimura H, Minagawa M, Ito A, Tomiyama K, Ito M (2002). "Expression of functional Toll-like receptor 2 on human epidermal keratinocytes." J Dermatol Sci 30(3):185-94.

    Epidermal keratinocytes secrete cytokines, chemokines, and anti-microbial peptides in response to various microbial pathogens and their components including lipopolysaccharide (LPS). To identify the receptor(s) involved in the anti-microbial responses of epidermal keratinocytes, we analyzed expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 on cultured normal human epidermal keratinocytes (NHEK). Although CD14 and TLR2 mRNA were expressed in cultured NHEK, only TLR2 was detected on the cell surface. Cultured NHEK did not express TLR4 mRNA or protein. Commercial LPS preparations could stimulate epidermal keratinocytes to produce beta-defensin-2 and IL-8, and the LPS response was inhibited with mAb specific for TLR2, but not for CD14 or TLR4. Repurified LPS and lipid A did not stimulate epidermal keratinocytes, whereas peptidoglycan (PGN) from Gram-positive bacteria and yeast cell wall particle induced beta-defensin-2 and IL-8 production. Thus, cultured NHEK express functional TLR2, but not CD14 or TLR4, and the "LPS" response of epidermal keratinocytes shown in the previous studies might be mediated by TLR2-dependent recognition of non-LPS bacterial components contaminating in commercial LPS preparations. In the normal human skin, however, epidermal keratinocytes expressed both TLR2 and TLR4. Because TLR4 was induced in epidermal keratinocytes by in vitro stimulation with PGN from Gram-positive bacteria, constitutive expression of TLR4 on epidermal keratinocytes in vivo might also be induced by continuous recognition of the resident skin flora containing Gram-positive bacteria through TLR2.

  • in vitro blocking of TLR4 signaling
    Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC (2002). "Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4." J Exp Med 195(1):99-111.

    Low molecular weight fragmentation products of the polysaccharide of Hyaluronic acid (sHA) produced during inflammation have been shown to be potent activators of immunocompetent cells such as dendritic cells (DCs) and macrophages. Here we report that sHA induces maturation of DCs via the Toll-like receptor (TLR)-4, a receptor complex associated with innate immunity and host defense against bacterial infection. Bone marrow-derived DCs from C3H/HeJ and C57BL/10ScCr mice carrying mutant TLR-4 alleles were nonresponsive to sHA-induced phenotypic and functional maturation. Conversely, DCs from TLR-2-deficient mice were still susceptible to sHA. In accordance, addition of an anti-TLR-4 mAb to human monocyte-derived DCs blocked sHA-induced tumor necrosis factor alpha production. Western blot analysis revealed that sHA treatment resulted in distinct phosphorylation of p38/p42/44 MAP-kinases and nuclear translocation of nuclear factor (NF)-kappa B, all components of the TLR-4 signaling pathway. Blockade of this pathway by specific inhibitors completely abrogated the sHA-induced DC maturation. Finally, intravenous injection of sHA-induced DC emigration from the skin and their phenotypic and functional maturation in the spleen, again depending on the expression of TLR-4. In conclusion, this is the first report that polysaccharide degradation products of the extracellular matrix produced during inflammation might serve as an endogenous ligand for the TLR-4 complex on DCs.

  • in vitro blocking of TLR4 signaling
    Tada H, Nemoto E, Shimauchi H, Watanabe T, Mikami T, Matsumoto T, Ohno N, Tamura H, Shibata K, Akashi S, Miyake K, Sugawara S, Takada H (2002). "Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor

    The cytokine-inducing activities of fungal polysaccharides were examined in human monocytes in culture, with special reference to CD14 and Toll-like receptors (TLRs). Tumor necrosis factor alpha (TNF-alpha) production by monocytes was markedly induced in a dose-dependent manner upon stimulation with cell walls from Candida albicans and mannan from Saccharomyces cerevisiae and C. albicans, although relatively high concentrations (10 to 100 microg/ml) of stimulants were required for activation as compared with the reference lipopolysaccharide (LPS) (1 to 10 ng/ml). The yeast form C. albicans and its mannan and cell wall fractions exhibited higher TNF-alpha production than respective preparations from the hyphal form. Only slight TNF-alpha production was induced by the S. cerevisiae glucan. The TNF-alpha production triggered by reference LPS and purified fungal mannans required the presence of LPS-binding protein (LBP), and these responses were inhibited by anti-CD14 and anti-TLR4 antibodies, but not by anti-TLR2 antibody. In contrast to the activity of LPS, the activity of purified S. cerevisiae mannan was not inhibited by polymyxin B. These findings suggested that the mannan-LBP complex is recognized by CD14 on monocytes and that signaling through TLR4 leads to the production of proinflammatory cytokines in a manner similar to that induced by LPS.

Product FAQs

Related Products

  1. Catalog #BE0505
    InVivoMAb anti-mouse TLR4 (CD284) Read more